Pulmonary langerhans cell histiocytosis

Orphanet Journal of Rare Diseases

Volumn 7, Issue 1, 2012, Pages

  Suri, Harpreet S ^a   Yi, Eunhee S ^a   Nowakowski, Gregorz S ^a   Vassallo, Robert ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

Bronchiolitis; Cigarette smoke; Interstitial; Langerhans cells; Pulmonary hypertension

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PROSTACYCLIN; VASODILATOR AGENT;

ANTICOAGULANT THERAPY; BRONCHOSCOPY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; ECHOCARDIOGRAPHY; GLUCOSE TRANSPORT; HEART LUNG TRANSPLANTATION; HEREDITY; HIGH RESOLUTION CHEST COMPUTED TOMOGRAPHY; HISTIOCYTOSIS; HISTOPATHOLOGY; HUMAN; HYPOXEMIA; INCIDENCE; LANGERHANS CELL; LUNG BIOPSY; LUNG DISEASE; LUNG FUNCTION; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN THERAPY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY LANGERHANS CELL HISTIOCYTOSIS; RARE DISEASE; REVIEW; SMOKING CESSATION; THORAX RADIOGRAPHY; VEIN OCCLUSION; ADULT; FEMALE; HISTIOCYTOSIS X; IMMUNOLOGY; INFANT; LUNG FUNCTION TEST; MALE; PATHOLOGY; PNEUMOTHORAX; PRESCHOOL CHILD; SMOKING;

ADULT; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; HYPERTENSION, PULMONARY; INFANT; LANGERHANS CELLS; LUNG DISEASES; MALE; PNEUMOTHORAX; PROGNOSIS; RESPIRATORY FUNCTION TESTS; SMOKING; YOUNG ADULT;

EID: 84858307867     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-7-16     Document Type: Review

References (105)

1. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, Bucsky P, Egeler RM, Elinder G, Gadner H, et al. Med Pediatr Oncol 1997 29 3 157 166 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO;2-C 9212839
2. Histiocytosis × histogenetic arguments for a Langerhans cell origin. Nezelof C, Basset F, Rousseau MF, Biomedicine 1973 18 5 365 371 4356601
3. [Histiocytosis X: a differentiated histiocytic process]. Nezelof C, Basset F, Diebold N, Pathol Biol (Paris) 1975 23 6 499
4. Historical perspectives of Langerhans cell histiocytosis. Komp DM, Hematol Oncol Clin North Am 1987 1 1 9 21 3312151 (Pubitemid 18071789)
5. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH, N Engl J Med 2002 346 7 484 490 10.1056/NEJMoa012087 11844849 (Pubitemid 34441739)
6. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, Grois N, Emile JF, Lukina E, Danesino C, Eur J Cancer 2003 39 16 2341 2348 10.1016/S0959-8049(03)00672-5 14556926 (Pubitemid 37214858)
7. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Salotti JA, Nanduri V, Pearce MS, Parker L, Lynn R, Windebank KP, Arch Dis Child 2009 94 5 376 380 10.1136/adc.2008.144527 19060008
8. Incidence and survival of childhood Langerhans cell histiocytosis in Northwest England from 1954 to 1998. Alston RD, Tatevossian RG, McNally RJ, Kelsey A, Birch JM, Eden TO, Pediatric blood & cancer 2007 48 5 555 560 10.1002/pbc.20884 22489085 (Pubitemid 46496352)
9. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenographic, and physiological correlations in 502 patients. Gaensler EA, Carrington CB, Ann Thorac Surg 1980 30 5 411 426 10.1016/S0003-4975(10)61291-X 7436611 (Pubitemid 10029440)
10. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Travis WD, Borok Z, Roum JH, Zhang J, Feuerstein I, Ferrans VJ, Crystal RG, Am J Surg Pathol 1993 17 10 971 986 10.1097/00000478-199310000-00002 8372949 (Pubitemid 23289339)
11. Eosinophilic granuloma of lung Clinical aspects of primary histiocytosis in the adult. Friedman PJ, Liebow AA, Sokoloff J, Med (Baltimore) 1981 60 6 385 396 10.1097/00005792-198111000-00001 (Pubitemid 12207233)
12. Clinical and radiologic features, lung function and therapeutic results in pulmonary histiocytosis X. Schonfeld N, Frank W, Wenig S, Uhrmeister P, Allica E, Preussler H, Grassot A, Loddenkemper R, Respiration 1993 60 1 38 44 8480089 (Pubitemid 23117206)
13. Clinico-epidemiological features of pulmonary histiocytosis X. Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T, Internal medicine (Tokyo, Japan) 2001 40 10 998 1003 10.2169/internalmedicine.40.998 (Pubitemid 33041139)
14. Familial clustering of Langerhans cell histiocytosis. Arico M, Nichols K, Whitlock JA, Arceci R, Haupt R, Mittler U, Kuhne T, Lombardi A, Ishii E, Egeler RM, et al. Br J Haematol 1999 107 4 883 888 10.1046/j.1365-2141.1999.01777.x 10606898 (Pubitemid 30020164)
15. Familial pulmonary histiocytosis-X. Hirsch MS, Hong CK, Am Rev Respir Dis 1973 107 5 831 835 4695633
16. Outcome in children with pulmonary Langerhans cell Histiocytosis. Braier J, Latella A, Balancini B, Castanos C, Rosso D, Chantada G, Ripoli M, Goldberg J, Pediatric blood & cancer 2004 43 7 765 769 10.1002/pbc.20112 22489085 (Pubitemid 39557713)
17. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood. Odame I, Li P, Lau L, Doda W, Noseworthy M, Babyn P, Weitzman S, Pediatric blood & cancer 2006 47 7 889 893 10.1002/pbc.20676 22489085 (Pubitemid 44656110)
18. Pulmonary Langerhans Cell Histiocytosis: A Comparative Study of Computed Tomography in Children and Adults. Seely JM, Salahudeen S Sr, Cadaval-Goncalves AT, Jamieson DH, Dennie CJ, Matzinger FR, Souza CA, Journal of thoracic imaging 2010
19. Pulmonary histiocytosis X: evaluation with high-resolution CT. Brauner MW, Grenier P, Mouelhi MM, Mompoint D, Lenoir S, Radiology 1989 172 1 255 258 2787036 (Pubitemid 19192519)
20. Accuracy of high-resolution CT in diagnosing lung diseases. Bonelli FS, Hartman TE, Swensen SJ, Sherrick A, AJR Am J Roentgenol 1998 170 6 1507 1512 9609163 (Pubitemid 28237639)
21. Imaging of pulmonary histiocytosis X. Kulwiec EL, Lynch DA, Aguayo SM, Schwarz MI, King TE Jr, Radiographics 1992 12 3 515 526 1609142
22. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease [see comments]. Willman CL, Busque L, Griffith BB, Favara BE, McClain KL, Duncan MH, Gilliland DG, N Engl J Med 1994 331 3 154 160 10.1056/NEJM199407213310303 8008029 (Pubitemid 24209565)
23. Detection of clonal histiocytes in Langerhans cell histiocytosis: biology and clinical significance. Willman CL, Br J Cancer Suppl 1994 23 29 S33 7521201
24. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis. Yu RC, Chu C, Buluwela L, Chu AC, Lancet 1994 343 8900 767 768 10.1016/S0140-6736(94)91842-2 7510816 (Pubitemid 24098697)
25. Pulmonary Langerhans' cell histiocytosis: molecular analysis of clonality. Yousem SA, Colby TV, Chen YY, Chen WG, Weiss LM, Am J Surg Pathol 2001 25 5 630 636 10.1097/00000478-200105000-00010 11342775 (Pubitemid 32423361)
26. A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. Gadner H, Grois N, Arico M, Broadbent V, Ceci A, Jakobson A, Komp D, Michaelis J, Nicholson S, Potschger U, et al. J Pediatr 2001 138 5 728 734 10.1067/mpd.2001.111331 11343051 (Pubitemid 32417676)
27. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. Ladisch S, Gadner H, Arico M, Broadbent V, Grois N, Jacobson A, Komp D, Nicholson HS, Med Pediatr Oncol 1994 23 2 107 110 10.1002/mpo.2950230207 8202031 (Pubitemid 24213323)
28. Pulmonary Langerhans' cell histiocytosis: radiologic resolution following smoking cessation. Mogulkoc N, Veral A, Bishop PW, Bayindir U, Pickering CA, Egan JJ, Chest 1999 115 5 1452 1455 10.1378/chest.115.5.1452 10334170 (Pubitemid 29230663)
29. Complete resolution of roentgenographic changes in a patient with pulmonary histiocytosis X. Von Essen S, West W, Sitorius M, Rennard SI, Chest 1990 98 3 765 767 10.1378/chest.98.3.765 2394160 (Pubitemid 20352724)
30. Smoking preceded pulmonary involvement in adults with Langerhans cell histiocytosis diagnosed in childhood. Bernstrand C, Cederlund K, Ashtrom L, Henter JI, Acta Paediatr 2000 89 11 1389 1392 10.1111/j.1651-2227.2000.tb00772.x 11106057
31. Histiocytosis × in the lung. Colby TV, Lombard C, Hum Pathol 1983 14 10 847 856 10.1016/S0046-8177(83)80160-9 6352456
32. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Vassallo R, Jensen EA, Colby TV, Ryu JH, Douglas WW, Hartman TE, Limper AH, Chest 2003 124 4 1199 1205 10.1378/chest.124.4.1199 14555547 (Pubitemid 37290027)
33. Taking dendritic cells into medicine. Steinman RM, Banchereau J, Nature 2007 449 7161 419 426 10.1038/nature06175 17898760 (Pubitemid 47509552)
34. Dendritic cells and the control of immunity. Banchereau J, Steinman RM, Nature 1998 392 6673 245 252 10.1038/32588 9521319 (Pubitemid 28155090)
35. Pulmonary dendritic cells. Vermaelen K, Pauwels R, Am J Respir Crit Care Med 2005 172 5 530 551 10.1164/rccm.200410-1384SO 15879415 (Pubitemid 41232964)
36. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. Holt PG, Haining S, Nelson DJ, Sedgwick JD, J Immunol 1994 153 1 256 261 8207240 (Pubitemid 24186538)
37. Accumulation of Langerhans' cells on the epithelial surface of the lower respiratory tract in normal subjects in association with cigarette smoking. Casolaro MA, Bernaudin JF, Saltini C, Ferrans VJ, Crystal RG, Am Rev Respir Dis 1988 137 2 406 411 3277501 (Pubitemid 18050192)
38. Cigarette smoking-induced changes in the number and differentiated state of pulmonary dendritic cells/Langerhans cells. Soler P, Moreau A, Basset F, Hance AJ, Am Rev Respir Dis 1989 139 5 1112 1117 2712439 (Pubitemid 19139830)
39. Function-associated surface molecules on airway dendritic cells in cigarette smokers. Bratke K, Klug M, Bier A, Julius P, Kuepper M, Virchow JC, Lommatzsch M, Am J Respir Cell Mol Biol 2008 38 6 655 660 10.1165/rcmb.2007- 0400OC 18203971 (Pubitemid 351841566)
40. Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X. Auerswald U, Barth J, Magnussen H, Lung 1991 169 6 305 309 1758200
41. Diagnosis of pulmonary histiocytosis × by immunodetection of Langerhans cells in bronchoalveolar lavage fluid. Chollet S, Soler P, Dournovo P, Richard MS, Ferrans VJ, Basset F, Am J Pathol 1984 115 2 225 232 6372496 (Pubitemid 14145904)
42. Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung. Colasante A, Poletti V, Rosini S, Ferracini R, Musiani P, Am Rev Respir Dis 1993 148 3 752 759 10.1164/ajrccm/148.3.752 7690210 (Pubitemid 23263790)
43. Cigarette smoke promotes dendritic cell accumulation in COPD; a Lung Tissue Research Consortium study. Vassallo R, Walters PR, Lamont J, Kottom TJ, Yi ES, Limper AH, Respir Res 2010 11 45 10.1186/1465-9921-11-45 20420706
44. Tobacco smoke induced lung granulomas and tumors: association with pulmonary Langerhans cells. Zeid NA, Muller HK, Pathology 1995 27 3 247 254 10.1080/00313029500169063 8532391
45. Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophages. Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, Kilty I, Rahman I, Am J Physiol 2006 291 1 46 L57
46. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J, Nature 1992 360 6401 258 261 10.1038/360258a0 1279441
47. Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells. Hellermann GR, Nagy SB, Kong X, Lockey RF, Mohapatra SS, Respir Res 2002 3 22 10.1186/rr172 12204101 (Pubitemid 41358114)
48. Role of granulocyte-macrophage colony stimulating factor (GM-CSF) in the pathogenesis of adult pulmonary histiocytosis X. Tazi A, Bonay M, Bergeron A, Grandsaigne M, Hance AJ, Soler P, Thorax 1996 51 6 611 614 10.1136/thx.51.6.611 8693443 (Pubitemid 26226516)
49. Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. Churg A, Tai H, Coulthard T, Wang R, Wright JL, Am J Respir Crit Care Med 2006 174 12 1327 1334 10.1164/rccm.200605-585OC 17008639 (Pubitemid 44913034)
50. Tissue localization of transforming growth factor-beta1 in pulmonary eosinophilic granuloma. Asakura S, Colby TV, Limper AH, Am J Respir Crit Care Med 1996 154 5 1525 1530 8912775 (Pubitemid 26391208)
51. CD34+ cell-derived CD14+ precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. Jaksits S, Kriehuber E, Charbonnier AS, Rappersberger K, Stingl G, Maurer D, J Immunol 1999 163 9 4869 4877 10528188 (Pubitemid 29501251)
52. Regulation of immune responses by TGF-beta. Letterio JJ, Roberts AB, Annu Rev Immunol 1998 16 137 161 10.1146/annurev.immunol.16.1.137 9597127 (Pubitemid 28183362)
53. D'Hulst A I, Maes T, Moerloose KB, Demedts IK, Lebecque S, Joos GF, Brusselle GG: Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. Bracke KR, J Immunol 2006 177 7 4350 4359 16982869 (Pubitemid 44469763)
54. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Merad M, Ginhoux F, Collin M, Nature reviews 2008 8 12 935 947 10.1038/nri2455 19029989
55. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, Gurusiddappa S, Phillips MT, Hicks MJ, Gaikwad A, et al. J Immunol 2010 184 8 4557 4567 10.4049/jimmunol.0902336 20220088
56. Essential role of osteopontin in smoking-related interstitial lung diseases. Prasse A, Stahl M, Schulz G, Kayser G, Wang L, Ask K, Yalcintepe J, Kirschbaum A, Bargagli E, Zissel G, et al. Am J Pathol 2009 174 5 1683 1691 10.2353/ajpath.2009.080689 19359522
57. Expression of apoptosis-regulatory proteins in lesions of pulmonary Langerhans cell histiocytosis. Marchal J, Kambouchner M, Tazi A, Valeyre D, Soler P, Histopathology 2004 45 1 20 28 10.1111/j.1365-2559.2004.01875.x 15228440 (Pubitemid 38969558)
58. Evidence that Langerhans cells in adult pulmonary Langerhans cell histiocytosis are mature dendritic cells: importance of the cytokine microenvironment. Tazi A, Moreau J, Bergeron A, Dominique S, Hance AJ, Soler P, J Immunol 1999 163 6 3511 3515 10477625 (Pubitemid 29431857)
59. Surface phenotype of Langerhans cells and lymphocytes in granulomatous lesions from patients with pulmonary histiocytosis X. Tazi A, Bonay M, Grandsaigne M, Battesti JP, Hance AJ, Soler P, Am Rev Respir Dis 1993 147 6 Pt 1 1531 1536 8503566 (Pubitemid 23160558)
60. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. Hayashi T, Rush WL, Travis WD, Liotta LA, Stetler-Stevenson WG, Ferrans VJ, Arch Pathol Lab Med 1997 121 9 930 937 9302924 (Pubitemid 28052921)
61. Expression of matrix metalloproteinase-9 and significance of a macrophage assay in eosinophilic granuloma. Zyada MM, Ann Diagn Pathol 2009 13 6 367 372 10.1016/j.anndiagpath.2009.06.009 19917471
62. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Coury F, Annels N, Rivollier A, Olsson S, Santoro A, Speziani C, Azocar O, Flacher M, Djebali S, Tebib J, et al. Nature medicine 2008 14 1 81 87 10.1038/nm1694 18157139
63. Interleukin-17 and type 17 helper T cells. Miossec P, Korn T, Kuchroo VK, N Engl J Med 2009 361 9 888 898 10.1056/NEJMra0707449 19710487
64. Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Allen CE, McClain KL, Nature medicine 2009 15 5 483 484 author reply 484-485 10.1038/nm0509-483 19424201
65. Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses. Vassallo R, Kroening PR, Parambil J, Kita H, Mol Immunol 2008 45 12 3321 3329 10.1016/j.molimm.2008.04.014 18533267
66. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L, J Immunol 2005 175 4 2684 2691 16081845 (Pubitemid 41113884)
67. Cigarette smoke-induced oxidative stress suppresses generation of dendritic cell IL-12 and IL-23 through ERK-dependent pathways. Kroening PR, Barnes TW, Pease L, Limper A, Kita H, Vassallo R, J Immunol 2008 181 2 1536 1547 18606709
68. Severe pulmonary hypertension in histiocytosis X. Fartoukh M, Humbert M, Capron F, Maitre S, Parent F, Le Gall C, Sitbon O, Herve P, Duroux P, Simonneau G, Am J Respir Crit Care Med 2000 161 1 216 223 10619823 (Pubitemid 30055928)
69. Three-dimensional characterization of pathologic lesions in pulmonary langerhans cell histiocytosis. Kambouchner M, Basset F, Marchal J, Uhl JF, Hance AJ, Soler P, Am J Respir Crit Care Med 2002 166 11 1483 1490 10.1164/rccm.2201050 12450935 (Pubitemid 35387299)
70. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo. Birbeck MS, Breathnach AS, Everall JD, J Invest Dermatol 1961 37 51 63
71. Langerin/CD207 sheds light on formation of birbeck granules and their possible function in Langerhans cells. Valladeau J, Dezutter-Dambuyant C, Saeland S, Immunol Res 2003 28 2 93 107 10.1385/IR:28:2:93 14610287 (Pubitemid 37465160)
72. Dendritic cells accumulate in human fibrotic interstitial lung disease. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, Kambouchner M, Valeyre D, Crestani B, Soler P, Am J Respir Crit Care Med 2007 176 10 1007 1014 10.1164/rccm.200609- 1347OC 17717200 (Pubitemid 350127845)
73. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Inoshima N, Nakanishi Y, Minami T, Izumi M, Takayama K, Yoshino I, Hara N, Clin Cancer Res 2002 8 11 3480 3486 12429638 (Pubitemid 35340725)
74. Normal chest roentgenograms in chronic diffuse infiltrative lung disease. Epler GR, McLoud TC, Gaensler EA, Mikus JP, Carrington CB, N Engl J Med 1978 298 17 934 939 10.1056/NEJM197804272981703 642974 (Pubitemid 8325838)
75. Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Lacronique J, Roth C, Battesti JP, Basset F, Chretien J, Thorax 1982 37 2 104 109 10.1136/thx.37.2.104 6979115 (Pubitemid 12135585)
76. Cigarette smoking: CT and pathologic findings of associated pulmonary diseases. Hartman TE, Tazelaar HD, Swensen SJ, Muller NL, Radiographics 1997 17 2 377 390 9084079 (Pubitemid 127465063)
77. Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans [see comments]. Brauner MW, Grenier P, Tijani K, Battesti JP, Valeyre D, Radiology 1997 204 2 497 502 9240543 (Pubitemid 27337502)
78. Central nervous system disease in Langerhans cell histiocytosis. Grois N, Tsunematsu Y, Barkovich AJ, Favara BE, Br J Cancer Suppl 1994 23 24 S28 8075002
79. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Phillips M, Allen C, Gerson P, McClain K, Pediatric blood & cancer 2009 52 1 97 101 10.1002/pbc.21782 22489085
80. PET-CT in pediatric Langerhans cell histiocytosis. Kaste SC, Rodriguez-Galindo C, McCarville ME, Shulkin BL, Pediatr Radiol 2007 37 7 615 622 10.1007/s00247-007-0467-4 17564738 (Pubitemid 46929934)
81. Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis. Krajicek BJ, Ryu JH, Hartman TE, Lowe VJ, Vassallo R, Chest 2009 135 6 1542 1549 10.1378/chest.08-1899 19447918
82. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE Jr, Am J Respir Crit Care Med 1996 153 1 426 435 8542154 (Pubitemid 26026885)
83. Evaluation Of The Course Of Adult Pulmonary Langerhans Cell Histiocytosis By Serial Lung Function Tests. Tazi A, Marc K, Dominique S, De Bazelaire C, Crestani B, Chinet T, Israel-Biet D, Cadranel J, Frija J, Bergeron A, et al. Am J Respir Crit Care Med 2011 183 1620 10.1164/rccm.201102-0275UP
84. Transbronchial biopsy in patients with pulmonary eosinophilic granuloma. Comparison with findings on open lung biopsy. Housini I, Tomashefski JF Jr, Cohen A, Crass J, Kleinerman J, Arch Pathol Lab Med 1994 118 5 523 530 7514863 (Pubitemid 24176830)
85. The clinical role of BAL in pulmonary histiocytosis X. Danel C, Israel-Biet D, Costabel U, Rossi GA, Wallaert B, Eur Respir J 1990 3 8 949 950 961-949 2292298
86. Primary cystic lung light chain deposition disease: a clinicopathologic entity derived from unmutated B cells with a stereotyped IGHV4-34/IGKV1 receptor. Colombat M, Mal H, Copie-Bergman C, Diebold J, Damotte D, Callard P, Fournier M, Farcet JP, Stern M, Delfau-Larue MH, Blood 2008 112 5 2004 2012 10.1182/blood-2007-11-123596 18483396
87. Langerhans cell histiocytosis: a review of past, current and future therapies. Allen CE, McClain KL, Drugs Today (Barc) 2007 43 9 627 643 10.1358/dot.2007.43.9.1088823 (Pubitemid 350004868)
88. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. Tazi A, Montcelly L, Bergeron A, Valeyre D, Battesti JP, Hance AJ, Am J Respir Crit Care Med 1998 157 6 Pt 1 2007 2010 9620939
89. Langerhans cell histiocytosis: diagnosis, natural history, management, and outcome. Howarth DM, Gilchrist GS, Mullan BP, Wiseman GA, Edmonson JH, Schomberg PJ, Cancer 1999 85 10 2278 2290 10.1002/(SICI)1097-0142(19990515)85: 10<2278::AID-CNCR25>3.0.CO;2-U 10326709 (Pubitemid 29215570)
90. Cladribine activity in adult langerhans-cell histiocytosis. Saven A, Burian C, Blood 1999 93 12 4125 4130 10361109 (Pubitemid 29279254)
91. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis. Pardanani A, Phyliky RL, Li CY, Tefferi A, Mayo Clin Proc 2003 78 3 301 306 10.4065/78.3.301 12630583 (Pubitemid 36259298)
92. Progressive diffuse pulmonary Langerhans cell histiocytosis improved by cladribine chemotherapy. Lazor R, Etienne-Mastroianni B, Khouatra C, Tazi A, Cottin V, Cordier JF, Thorax 2009 64 3 274 275 10.1136/thx.2008.108944 19252036
93. Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy. Carrera CJ, Terai C, Lotz M, Curd JG, Piro LD, Beutler E, Carson DA, J Clin Invest 1990 86 5 1480 1488 10.1172/JCI114865 1700795 (Pubitemid 20372594)
94. Complete remission of nodular pulmonary Langerhans cell histiocytosis lesions induced by 2-chlorodeoxyadenosine in a non-smoker. Aerni MR, Christine Aubry M, Myers JL, Vassallo R, Respiratory Med 2008 102 2 316 319 10.1016/j.rmed.2007.09.002 (Pubitemid 350296904)
95. Successful treatment of Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Goh NS, McDonald CE, MacGregor DP, Pretto JJ, Brodie GN, Respirology (Carlton, Vic 2003 8 1 91 94 10.1046/j.1440-1843.2003.00427.x (Pubitemid 36504287)
96. Pneumothorax in pulmonary Langerhans cell histiocytosis. Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH, Chest 2004 125 3 1028 1032 10.1378/chest.125.3.1028 15006964 (Pubitemid 38367296)
97. Sudden death of a patient with pulmonary Langerhans cell histiocytosis. Nakhla H, Jumbelic MI, Arch Pathol Lab Med 2005 129 6 798 799 15913433 (Pubitemid 40734527)
98. Advanced pulmonary histiocytosis × is associated with severe pulmonary hypertension. Harari S, Brenot F, Barberis M, Simmoneau G, Chest 1997 111 4 1142 1144 9106608
99. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Chaowalit N, Pellikka PA, Decker PA, Aubry MC, Krowka MJ, Ryu JH, Vassallo R, Mayo Clin Proc 2004 79 10 1269 1275 10.4065/79.10.1269 15473409 (Pubitemid 39299072)
100. Pulmonary veno-occlusive disease in pulmonary Langerhans' cell granulomatosis. Hamada K, Teramoto S, Narita N, Yamada E, Teramoto K, Kobzik L, Eur Respir J 2000 15 2 421 423 10.1034/j.1399-3003.2000.15b33.x 10706515 (Pubitemid 30085976)
101. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Dauriat G, Mal H, Thabut G, Mornex JF, Bertocchi M, Tronc F, Leroy-Ladurie F, Dartevelle P, Reynaud-Gaubert M, Thomas P, et al. Transplantation 2006 81 5 746 750 10.1097/01.tp.0000200304.64613.af 16534477
102. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Delobbe A, Durieu J, Duhamel A, Wallaert B, Eur Respir J 1996 9 10 2002 2006 10.1183/09031936.96.09102002 8902457
103. Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma. Feuillet S, Louis L, Bergeron A, Berezne A, Dubreuil ML, Polivka M, Oksenhendler E, Tazi A, Eur Respir Rev 2011 19 115 86 88
104. Histiocytosis × arising in Hodgkin's disease: immunophenotypic characterization with a panel of monoclonal antibodies. Coli A, Bigotti G, Ferrone S, Virchows Arch A Pathol Anat Histopathol 1991 418 4 369 373 10.1007/BF01600168 1708928
105. Langerhans cell granulomatosis (histiocytosis X) associated with malignant lymphomas. Burns BF, Colby TV, Dorfman RF, Am J Surg Pathol 1983 7 529 531 10.1097/00000478-198309000-00003 6605095